Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Neptune Technologies & Bioressources Inc, Acasti Pharma Inc and NeuroBioPharm Inc announce resignation of chief executive officer


Monday, 28 Apr 2014 08:00am EDT 

Neptune Technologies & Bioressources Inc, Acasti Pharma Inc and NeuroBioPharm Inc:Jointly announce the resignation of Henri Harland as president and chief executive officer of Neptune, Acasti and NeuroBio with immediate effect.Harland remains a Director of Neptune, Acasti and NeuroBio.Search for a new president and chief executive officer will commence immediately. 

Company Quote

0.5298
0.0018 +0.34%
30 Oct 2014